Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Internal wind suppression" is not a scientifically defined molecular or protein target but rather a functional concept in Traditional Chinese Medicine (TCM). The term refers to the treatment principle of managing or "suppressing" internal wind, thought in TCM to cause symptoms such as tremor, convulsions, dizziness, or stroke-like presentations. No corresponding single protein, receptor, enzyme, or other standard molecular target exists. Modern pharmacology and molecular medicine do not currently use or recognize "internal wind suppression" as a molecular target. For structured biomedical information, the term should be mapped and replaced with the precise syndrome, symptom, or known target relevant to the biomedical context (e.g., voltage-gated ion channels involved in epilepsy or essential tremor). If you need information about potential molecular targets underlying "internal wind" symptoms in TCM (such as GABA-A receptor, NMDA receptor, or voltage-gated sodium channels), please specify the symptom or modern disease context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Internal wind suppression.